Header cover image

U.S. Life Sciences Industry Analysis

UpdatedDec 20, 2024
DataAggregated Company Financials
Companies67
  • 7D-3.7%
  • 3M-13.8%
  • 1Y-6.6%
  • YTD-7.9%

Over the last 7 days, the Life Sciences industry has dropped 3.7%, driven by a pullback from Danaher of 3.6%. On the other hand Azenta is actually up 7.7%. The industry has fallen 6.6% in the last year. Earnings are forecast to grow by 18% annually.

Industry Valuation and Performance

Has the U.S. Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 21 Dec 2024US$644.4bUS$142.4bUS$10.2b43.6x63x4.5x
Mon, 18 Nov 2024US$638.7bUS$142.4bUS$10.4b41.8x61.6x4.5x
Wed, 16 Oct 2024US$736.4bUS$141.8bUS$8.5b37.3x86.7x5.2x
Fri, 13 Sep 2024US$738.4bUS$141.8bUS$8.5b37.7x86.9x5.2x
Sun, 11 Aug 2024US$727.5bUS$141.5bUS$8.5b38.2x85.8x5.1x
Tue, 09 Jul 2024US$664.6bUS$141.3bUS$12.2b38.8x54.6x4.7x
Thu, 06 Jun 2024US$705.0bUS$141.3bUS$12.4b39.9x56.7x5x
Sat, 04 May 2024US$708.1bUS$141.7bUS$12.5b38.9x56.6x5x
Mon, 01 Apr 2024US$744.3bUS$142.0bUS$12.8b44x58.2x5.2x
Wed, 28 Feb 2024US$728.5bUS$142.2bUS$12.8b44.1x57.1x5.1x
Fri, 26 Jan 2024US$686.7bUS$153.8bUS$14.2b35.1x48.5x4.5x
Sun, 24 Dec 2023US$698.9bUS$153.8bUS$14.2b37.5x49.1x4.5x
Tue, 21 Nov 2023US$610.6bUS$153.9bUS$13.9b33.5x43.9x4x
Thu, 19 Oct 2023US$612.3bUS$154.6bUS$11.2b31.8x54.7x4x
Sat, 16 Sep 2023US$692.7bUS$154.6bUS$11.2b33.3x61.8x4.5x
Mon, 14 Aug 2023US$725.3bUS$154.7bUS$11.5b32x63.1x4.7x
Wed, 12 Jul 2023US$695.5bUS$152.4bUS$12.5b29.7x55.6x4.6x
Fri, 09 Jun 2023US$680.8bUS$152.4bUS$12.5b29.1x54.5x4.5x
Sun, 07 May 2023US$703.0bUS$152.4bUS$12.9b30.5x54.6x4.6x
Tue, 04 Apr 2023US$722.6bUS$154.6bUS$10.8b26.8x66.9x4.7x
Thu, 02 Mar 2023US$707.6bUS$154.4bUS$10.9b29.8x64.9x4.6x
Sat, 28 Jan 2023US$761.6bUS$155.5bUS$9.0b31.1x84.7x4.9x
Mon, 26 Dec 2022US$743.5bUS$155.2bUS$8.8b28.8x84.7x4.8x
Wed, 23 Nov 2022US$760.2bUS$155.1bUS$8.8b28.5x86.7x4.9x
Fri, 21 Oct 2022US$680.5bUS$152.5bUS$17.0b24.3x40x4.5x
Sun, 18 Sep 2022US$752.0bUS$152.3bUS$17.3b28.6x43.4x4.9x
Tue, 16 Aug 2022US$846.3bUS$152.1bUS$17.3b32.7x49x5.6x
Thu, 14 Jul 2022US$739.2bUS$148.1bUS$20.1b30.2x36.8x5x
Sat, 11 Jun 2022US$712.0bUS$148.1bUS$20.1b29x35.4x4.8x
Mon, 09 May 2022US$736.4bUS$147.7bUS$20.0b31.2x36.8x5x
Wed, 06 Apr 2022US$871.5bUS$146.5bUS$25.3b36.2x34.4x5.9x
Fri, 04 Mar 2022US$849.1bUS$146.2bUS$25.3b37.8x33.6x5.8x
Sun, 30 Jan 2022US$829.5bUS$139.4bUS$27.9b38.8x29.8x6x
Tue, 28 Dec 2021US$994.9bUS$138.0bUS$27.3b45.6x36.4x7.2x
Price to Earnings Ratio

36.4x


Total Market Cap: US$994.9bTotal Earnings: US$27.3bTotal Revenue: US$138.0bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Life Sciences Industry Price to Earnings3Y Average 57x202220232024
Current Industry PE
  • Investors are optimistic on the American Life Sciences industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 63.0x which is higher than its 3-year average PE of 57.0x.
  • The industry is trading close to its 3-year average PS ratio of 4.9x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have declined 28% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare industry?

US Market-3.53%
Healthcare-3.69%
Life Sciences-3.74%
Clinical Research and Equipment-3.74%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AZTA AzentaUS$50.4312.2%
+US$250.7m
-21.8%PS3.5x
PSNL PersonalisUS$5.7550.5%
+US$136.4m
292.5%PS4.6x
WST West Pharmaceutical ServicesUS$331.400.4%
+US$97.8m
-6.6%PE48x
LAB Standard BioToolsUS$2.004.7%
+US$33.5m
0.5%PS4.8x
BLFS BioLife SolutionsUS$27.392.6%
+US$32.0m
70.9%PS8.6x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

PSNL

US$5.75

Personalis

7D

50.5%

1Y

292.5%

SHC

US$13.24

Sotera Health

7D

0.7%

1Y

-20.4%

LAB

US$2.00

Standard BioTools

7D

4.7%

1Y

0.5%

BLFS

US$27.39

BioLife Solutions

7D

2.6%

1Y

70.9%

DHR

US$228.55

Danaher

7D

-2.7%

1Y

-0.8%

WST

US$331.40

West Pharmaceutical Services

7D

0.4%

1Y

-6.6%

SYNH

US$42.98

Syneos Health

7D

0.6%

1Y

-8.8%